Commercial launch activities for Idefirix® progressing as planned Patient recruitment in the two phase 2 studies in AMR and GBS was...
Biopharma
~ Expects to Report KEVEYIS® (dichlorphenamide) Fourth Quarter 2020 Earnings of Somewhere around $8.2 Million and Entire-Yr 2020 Revenue of...
~ Expects to Report KEVEYIS® (dichlorphenamide) Fourth Quarter 2020 Revenue of Approximately $8.2 Million and Full-Year 2020 Revenue of Approximately...
By Rob Wright, Main Editor, Lifestyle Science LeaderAbide by Me On Twitter @RfwrightLSL It was 2015 when Everyday living Science...
